2008 (v1)
Publication
ABSTRACT Background Adjuvant chemotherapy with anthracyclines improves disease-free and overall survival compared with non – anthracycline-based adjuvant chemotherapy regimens in the treatment of early breast cancer. The role of HER2 status as a marker of anthracycline responsiveness has been explored by subset analyses within randomized...
Uploaded on: May 11, 2023